|
Demidova T.Yu., Titova V.V.
The role of self-monitoring of glycemia in the treatment of patients with type 2 diabetes mellitus and the achievement of the target level of carbohydrate metabolism
|
№5 / 2023
|
|
Semenova T.N., Grigoryeva V.N., Zanozina O.V., Sukhanov S.A.
Cognitive disorders in patients with hypertonic cerebral microangiopathy associated with type 2 diabetes mellitus and COVID-19
|
№5 / 2023
|
|
Panevin T.S., Eliseev M.S., Bobkova A.O., Dimitreva A.E., Urumova M.M.
Use of dapagliflozin in a comorbid patient: new opportunities
|
№3 / 2023
|
|
Podorozhnyuk K.V., Skuridina D.V.
The importance of a multifactorial approach in the treatment of type 2 diabetes mellitus: clinical cases
|
№8 / 2022
|
|
Demidova T.Yu., Izmailova M.Ya.
Chronic kidney disease and type 2 diabetes melitus: time determines the outcome
|
№8 / 2022
|
|
Volynkina A.P., Elizarova I.O., Karpenko Yu.Yu.
Assessment of information awareness in the prevention of type 2 diabetes among medical university students
|
№4 (приложение) / 2022
|
|
Demidova T.Yu., Mkrtumyan A.M.
Review of current opportunities in cardiovascular risks management in patients with type 2 diabetes mellitus
|
№9 / 2021
|
|
Ivanoshchuk D.E., Mikhailova S.V., Ovsyannikova A.K., Shakhtshneider E.V., Druk I.V., Rymar O.D., Voevoda M.I.
The G319S variants of the HNF1A gene in a family with diabetes mellitus
|
№9 / 2021
|
|
Sorokina L.N., Pavlova A.S., Mineev V.N., Trofimov V.I.
Chronic obstructive pulmonary disease in combination with type 2 diabetes mellitus: features of the clinical picture
|
№8 / 2021
|
|
Kunarbaeva A.K., Ivanov K.M., Petrova A.A., Krasikov S.I., Miroshnichenko I.V.
Peculiarities of changes in respiratory muscles strength and in lipid peroxidation processes in patients with type 2 diabetes mellitus
|
№5 / 2021
|
|
Demidova T.Yu., Alekseeva Ya.G.
The place of sodium glucose co-transporter-2 inhibitors in the treatment of type 2 diabetes mellitus and its complications from the evidence-based medicine viewpoint
|
№8 / 2020
|
|
Shishkova V.N., Martynov A.I.
Modern opportunities of therapy for metabolic cardiomyopathy and heart failure
|
№6 / 2020
|
Русский
